Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Colonic Neoplasms × Antioxidants × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Uterine Cervical Neoplasms 1 Radiation Injuries 1 Pelvic Inflammatory Disease 1 Colonic Neoplasms 1 Cardiovascular Diseases 1

Interventions

Fluorouracil 116 Leucovorin 109 Oxaliplatin 93 Irinotecan 80 Bevacizumab 49 Cetuximab 37 Capecitabine 36 Folfox protocol 28 Panitumumab 20 Colonoscopy 16 Floxuridine 15 Chemotherapy, Adjuvant 15 Early Intervention, Educational 12 Erlotinib Hydrochloride 11 Surveys and Questionnaires 10 Immunohistochemistry 10 IFL protocol 10 Counseling 10 Psychiatric Rehabilitation 8 Methods 8 Gemcitabine 8 Exercise 8 Dexamethasone 8 Celecoxib 8 Gene Expression Profiling 7 Cyclophosphamide 7 Blood Specimen Collection 7 sargramostim 6 Radiotherapy 6 Polymerase Chain Reaction 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02231203 2018-07-31

EMPIRE

Medical Center Alkmaar

Phase 4 Completed

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡